Skip to content

ECM

Eye Health News

  • Home
  • Conjunctivitis
  • Glaucoma
  • Cataract Surgery
  • Blog
Fielmann Group’s Preliminary 2025 Financial Results Show Growth as Company Concludes Vision 2025 Initiative HAMBURG, Germany—The Fielmann Group (ETR: FIE), a leading global eyewear provider, announced preliminary, unaudited results for the financial year 2025 that demonstrated overall growth. In making the announcement, the company reported generating total consolidated sales of €2,435 million, a 7.4 percent increase compared with the previous year of €2,267 million. According to the company, half…EYECAREFeb 13 2026
CooperVision Inducted Into Nova Southeastern University Fellows Society ROCHESTER, N.Y.—CooperVision announced that it has been inducted into the Nova Southeastern University (NSU) Fellows Society, the university’s premier recognition group honoring leaders whose cumulative giving exceeds $100,000 in support of the university.EYECAREFeb 13 2026
Top 10 Countries and Regions for LEED Ranking Outside the U.S. Are Announced WASHINGTON—The U.S. Green Building Council (USGBC), the global developer of the LEED (Leadership in Energy and Environmental Design) rating system, and Green Business Certification Inc. (GBCI), the organization independently recognizing excellence in green business industry performance and practices globally, has announced the annual Top 10 countries and regions for LEED ranking outside the United States…EYECAREFeb 12 2026
Colon Cancer Is Now the Deadliest Cancer for Young Adults Jenna Scott remembers the joy of being pregnant with her first and only child. She also remembers the immense abdominal pain. During her pregnancy, she let her doctors know about the persistent discomfort. She was told it was normal, that the aches “came with the territory,” she said.EYECAREFeb 12 2026
The Scary Health Risk That Can Sneak Up on GLP-1 Users Jennifer Lynn-Pullman had been taking Wegovy for a few months when she began shivering during a walk on a hot August day. "It was about 85 degrees–I should have been sweating," said Lynn-Pullman, a 48-year-old dietitian from Pennsylvania.EYECAREFeb 12 2026
EssilorLuxottica Reports Strong Q4 and 2025 Revenue Growth, Nods to Myopia Management Portfolio PARIS—EssilorLuxottica (Reuters: ESLX.PA) on Wednesday reported 2025 full-year financial results, with consolidated revenue reaching €28,491 million, a year-over-year increase of 11.2 percent at constant exchange rates, compared with full-year 2024. In the fourth quarter of 2025, the company reported consolidated revenue of €7,600 million, up 18.4 percent at constant exchange rates compared with the same…EYECAREFeb 12 2026
Hoya Vision Care Announces Leadership Changes to Advance North American Commercial, Operational Alignment LEWISVILLE, Texas—Hoya Vision Care, a global leader in ophthalmic lens technology, has announced North American leadership changes designed to strengthen its commercial and operational capabilities. Steven Haifawi, who currently serves as president of Hoya Vision Care Canada, will step into the role of senior vice president, U.S. Commercial, leading the company’s newly unified ECP sales,…EYECAREFeb 12 2026
Cira Collins, Victoria Hallberg and Kristen Tischler Join Lineup of Presenters at Most Influential Women in Optical Luncheon NEWARK, N.J.—Vision Monday is pleased to announce Cira Collins, optical coordinator for Kaiser Permanente, Victoria Hallberg, senior vice president of sales for Zyloware and Kenmark Eyewear, and Kristen Tischler, chief marketing officer at Advancing Eyecare, have joined the lineup of presenters for the 2026 Most Influential Women in Optical (MIWO) luncheon. This year’s special luncheon…EYECAREFeb 12 2026
OKYO Pharma Appoints Flavio Mantelli, MD, as Chief Medical Officer LONDON and NEW YORK—OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company, has announced the appointment of Flavio Mantelli, MD, Ph.D., as chief medical officer, effective immediately.EYECAREFeb 12 2026
Stanton Optical Opens First Four ‘Store-in-Store’ Locations Inside Staples Stores FRAMINGHAM, Mass. and DELRAY BEACH, Fla.—Now Optics, parent company of Stanton Optical, and Staples have announced the grand opening of the first four “store-in-store” Stanton Optical locations inside select Staples stores in the Philadelphia area.EYECAREFeb 12 2026
U.S. Small Business Employment Trends Hold Steady at Start of 2026, Paychex Says ROCHESTER, N.Y.—U.S. small businesses started 2026 with steady trends in job and wage growth, according to the January Paychex Small Business Employment Watch. The Small Business Jobs Index, which tracks payroll data for a subset of Paychex clients with fewer than 50 employees, slightly increased by 0.04 percentage points to 99.30 in January. Furthermore, the…EYECAREFeb 11 2026
Over 70 Percent of Tested Baby Foods Are Ultraprocessed and Full of Additives The vast majority of baby foods, drinks and snacks sold in the United States for children ages 6 months to 36 months are ultraprocessed and may contain additives increasingly linked to potential health harms, a new study found.EYECAREFeb 11 2026
What to Know About a New Study on Coffee, Tea, Caffeine and Dementia Risk A long-term analysis shows that people who drink caffeinated coffee and tea have a lower risk of developing dementia, although the study does not prove cause and effect. Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, warned that the results should be taken "with a massive grain…EYECAREFeb 11 2026
Metabolic Syndrome Tied to Glaucoma Risk Adults aged 40 years or older with metabolic syndrome were more likely to have glaucoma than their peers, whereas those with higher BMI or larger waist circumference were less likely to have this eye condition.EYECAREFeb 11 2026
NBEO Shares Continued Concerns Over Optometric Licensing Measures in Kentucky, Citing ‘Gaps in Public Protection’ NEWARK, N.J.—Controversy continues within the Kentucky optometric community following ongoing concerns after 21 optometrists in the state received licenses between 2020-2023 without passing all required parts of the National Board of Examiners in Optometry (NBEO) three-part exam. The dispute has its roots in pandemic-era adjustments the Kentucky Board of Optometric Examiners (KBOE) made to reduce…EYECAREFeb 11 2026
Kering Eyewear Reports Revenue for Fourth Quarter and Full-Year 2025 PARIS—Kering Eyewear, part of the global luxury group Kering (KER.PA), reported 2025 full-year revenue growth of 1 percent compared with the same period in 2024. During the group's earnings call yesterday, the company said overall revenue from the Kering Eyewear and corporate segment amounted to €1.6 billion, up 3 percent on a comparable basis for…EYECAREFeb 11 2026
World Council of Optometry Appoints Two New Trustees to Its Charitable Foundation ST. LOUIS—The World Council of Optometry (WCO) and World Optometry Foundation (WOF), WCO’s charitable arm dedicated to advancing global eye health and reducing avoidable blindness, have announced the appointment of Dr. Juan Carlos Aragón (Costa Rica) and Dr. Scott Mundle (Canada) to the WOF’s board of trustees. According to the announcement, Dr. Aragón and Dr.…EYECAREFeb 11 2026
Bridging Eye Disease Care With Addiction ServicesEric Gaier, MD, PhD, and Dean Eliott, MD, of the Department of Ophthalmology at Mass Eye and Ear, a member of the Mass General Brigham health care system, are co-authors of a paper published in Ophthalmology Retina, “Substance Use Disorder Interventions and Ophthalmic Outcomes for Injection Drug Use-Associated Endogenous Endophthalmitis.”EYECAREFeb 10 2026
Long COVID May Be Triggering Alzheimer’s-Like Changes in the Brain: New StudyThe effects of long COVID rage on. Over 20 million Americans are believed to have the debilitating post-infection condition, suffering symptoms such as severe fatigue, shortness of breath, chest pain, palpitations, dizziness and muscle pain.EYECAREFeb 10 2026
EssilorLuxottica Unveils Agenda for 3-Day SWITCH EventNEWARK, N.J.—EssilorLuxottica’s 3-day event titled “SWITCH: Vision Innovation Summit by EssilorLuxottica,” will be held March 9-11, 2026, in Orlando, Fla., and is designed to give ECPs a first look at the future of vision care.EYECAREFeb 10 2026
Stanton Optical Opens New Location in Royal Palm Beach, Fla.ROYAL PALM BEACH, Fla.—Stanton Optical, a leading retail brand under Now Optics, has announced the opening of its newest location in Royal Palm Beach, Fla. The opening marks Stanton Optical’s 45th location in Florida and 12th location in the West Palm Beach area.EYECAREFeb 10 2026
Review of Ophthalmology: Patient Selection Pearls for Presbyopia Drops“It’s 10 p.m., do you know where your reading glasses are?” For those with presbyopia, daily life can feel a little like that old public service commercial reminding parents to make sure their kids were home before curfew. Surgical correction methods are available, but not every patient is eligible, nor are they always interested in…EYECAREFeb 09 2026
Vision Monday Posts Its First-Ever Digital-Only Edition With January-February Double IssueNEWARK, N.J.—Vision Monday and Jobson Optical Group are proud to announce the release of their first-ever digital-only edition, now available here online. With this new approach that leans heavily into digital interactivity and video formats, VM brings readers even closer to today’s newsmakers, giving access to intimate, one-on-one conversations, exclusive interviews with key thought leaders,…EYECAREFeb 09 2026
Four Times as Many Measles Cases in a Few Weeks Than U.S. Typically Averages in a Whole Year: CDCThere have been at least 733 confirmed measles cases reported across the nation, the latest data from the Centers for Disease Control and Prevention showed Friday. In just a few weeks, the United States reported four times as many cases than typically seen throughout an entire calendar year, the CDC said.EYECAREFeb 09 2026
Risk-Based Breast Cancer Screening Nears a Turning PointThe case for replacing age-based breast cancer screening with personalized risk-based screening is gaining strength— with recent studies showing the approach is feasible and has the potential to save more lives.EYECAREFeb 09 2026
Erika Jurrens, Michelle Skinner to Present at VM’s 2026 Most Influential Women in Optical LuncheonNEW YORK—Vision Monday is pleased to announce the first featured presenters for the 2026 Most Influential Women in Optical (MIWO) luncheon include Erika Jurrens, senior vice president of ECP growth channels at EssilorLuxottica, and Michelle Skinner, chief provider solutions officer at VSP Vision. The special luncheon event and program to pay tribute to this year’s…EYECAREFeb 09 2026
Hoya Vision Care’s MiYOSMART iQ Lenses Show No Myopia Progression on Average at Six Months, Clinical Trial ShowsHONG KONG—Hoya Vision Care officially presented interim 6-month clinical evidence from a randomized controlled clinical trial evaluating the safety and efficacy of MiYOSMART iQ spectacle lenses in children aged 4-12 with progressive myopia at the 41st Asia-Pacific Academy of Ophthalmology Congress held here on February 6, the company announced. MiYOSMART iQ spectacle lenses are Hoya…EYECAREFeb 09 2026
American Optometric Association’s 2025 Advocacy Efforts Set the Stage for 2026, Group SaysST. LOUIS—The American Optometric Association (AOA) announced that it achieved several significant federal and state advocacy achievements for doctors and patients in 2025, including securing a 2.5 percent increase in Medicare physician reimbursement for 2026.EYECAREFeb 09 2026
SpyGlass Pharma Raises $150 Million in Initial Public OfferingALISO VIEJO, Calif.—SpyGlass Pharma, Inc. (Nasdaq: SGP), a late-stage biopharmaceutical company focused on intraocular lens and drug delivery solutions for chronic eye conditions such as glaucoma, announced it raised $150 million in its initial public offering (IPO).EYECAREFeb 09 2026
Johnson & Johnson Named Inaugural Global Impact Award Winner by the Healthcare Businesswomen's AssociationFAIRFIELD, N.J.—Johnson & Johnson (NYSE: JNJ) has been named the inaugural recipient of the Global Impact Award by the Healthcare Businesswomen's Association (HBA), a global leadership accelerator, business growth partner, and enterprise solution for the health care and life sciences industries.EYECAREFeb 09 2026
Patient Non-Adherence in the Optometric Setting: ODs Discuss Impact and SolutionsPatient non-adherence—which includes not following treatment plans, missing appointments, or failing to take medications as prescribed—is a complex issue which spans the health care spectrum, compromises patient safety and places a financial burden on health care systems. Non-adherence can be broadly separated into two categories: intentional (a conscious decision by the patient) or unintentional (caused…EYECAREFeb 06 2026
A New Study on Statins Reveals Surprise About Popular DrugsThe long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side effects are really a risk.EYECAREFeb 06 2026
Mediterranean Diet Can Reduce Risk of Stroke by up to 25 Percent, Long-Term Study SuggestsA Mediterranean diet can reduce the risk of every type of stroke, in some cases by as much as 25 percent, a large study conducted over two decades suggests.EYECAREFeb 06 2026
VIEW Optometry Launches Doctor-Led Alliance to Strengthen Independent EyecareBRENHAM, Texas—VIEW Optometry, a new doctor-led alliance dedicated to supporting private practice optometrists and protecting their independence, officially announced its launch yesterday. Founded by Tommy Lucas, OD, and Mary Kate Walters, OD, FAAO, the group aims to preserve and grow the private practice market segment, improve profitability and lessen financial pressures on optometry practices, and…EYECAREFeb 06 2026
Pearle Vision Celebrates 65th Anniversary, Reflects on Latest Year of Growth and InnovationNEW YORK—Pearle Vision, a leading national eyecare franchise, announced it is celebrating a landmark achievement in 2026 with the 65th anniversary of its founding by Dr. Stanley Pearle. This anniversary milestone underscores the brand’s lasting commitment to genuine eyecare, clinical excellence and community-based service, the company said in the announcement—values that have fueled Pearle’s growth…EYECAREFeb 06 2026
SECO International Reveals 2026 Awards of Excellence WinnersATLANTA—SECO International has announced the recipients of the 2026 SECO Awards of Excellence, recognizing extraordinary individuals and organizations whose dedication strengthens patient care, advances professional education, and elevates optometry across the South and beyond.EYECAREFeb 06 2026
Ocular Therapeutix Reports Fourth Quarter and Full Year 2025 Financials, Provides Business HighlightsBEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ: OCUL), an integrated biopharmaceutical company in the retina space, has reported financial results for the fourth quarter and year ended December 31, 2025, and provided recent business highlights.EYECAREFeb 06 2026
Clinique Joins Forces With Acuvue on Visionary Collaboration to Advance Eye Education in Beauty and VisionNEW YORK—Clinique has announced a visionary collaboration in the U.S. with Acuvue, a leading contact lens brand from Johnson & Johnson Vision, to advance eye education in beauty and vision by informing consumers that they can wear contacts and eye makeup confidently.EYECAREFeb 06 2026
Canadian Ophthalmological Society Highlights Advances in AMD Care During Awareness MonthThe Canadian Ophthalmological Society (COS) is marking Age-Related Macular Degeneration (AMD) Awareness Month by drawing attention to recent advances in care, the varied ways the disease affects patients, and the broader personal and societal impact of vision loss across Canada.EYECAREFeb 05 2026
Pink Noise May Be Bad for Sleep Quality, New Research FindsPink noise, a staticky sound that’s supposed to help people fall asleep, may actually worsen your rest, a new study found. Pink noise—like white noise—contains all the frequencies humans can hear, but it plays lower frequencies more prominently.EYECAREFeb 05 2026
Heart Attack, Stroke Risk Rises After Serious RSV, Study SaysAdults hospitalized with an acute respiratory syncytial virus (RSV) infection may face a sharp risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a retrospective self-controlled case study.EYECAREFeb 05 2026
Optical Women’s Association Expands Globally, Spotlights Courage and Authenticity in Leadership at MidoMILAN, Italy—The Optical Women’s Association (OWA) announced that it successfully hosted its OWA Global Connection Event at Mido in Milan, marking an important milestone in the organization’s continued international expansion and its mission to empower women in leadership roles across the global optical industry. OWA said the event, titled “Leading with Courage: Inspiring Stories of…EYECAREFeb 05 2026
Vision Expo and VSP Vision Name Finalists for 2026 VSP Vision Innovation ChallengeNORWALK, Conn. and RANCHO CORDOVA, Calif.—Vision Expo, produced by RX and The Vision Council, in collaboration with VSP Vision, a leader in health-focused vision care, announced the four startups that will participate in the 2026 VSP Vision Innovation Challenge.EYECAREFeb 05 2026
Pacific University’s Patrick Caroline Receives National Award For Specialty Contact Lens AdvocacyFOREST GROVE, Ore.—Pacific University has announced that associate professor of optometry Patrick Caroline has been honored for his longtime research and advocacy in the field of medically necessary specialty contact lenses.EYECAREFeb 05 2026
Vallon Expands North American Sales Team to Accelerate Retail Growth in Key MarketsAMSTERDAM—Vallon, an independently-owned outdoor eyewear brand, announced that it is expanding its North American presence with a dedicated six-person sales team, now covering key regions across the United States and Canada.EYECAREFeb 05 2026
Scientists Warn Against Breathing in Secondhand Vape ‘Smoke’Breathing in lingering, secondhand e-cigarette vapors has the potential to damage lung tissues. This is the warning of a new study by researchers from the University of California Riverside, who found that aged vape aerosols contain fine particles bearing metals and highly reactive compounds that can combine to produce harmful radical particles.EYECAREFeb 04 2026
When the Doctor Needs a CheckupHe was a surgical oncologist at a hospital in a Southern city, a 78-year-old whose colleagues had begun noticing troubling behavior in the operating room. During procedures, he seemed “hesitant, not sure of how to go on to the next step without being prompted” by assistants, said Mark Katlic, director of the Aging Surgeon Program…EYECAREFeb 04 2026
New Wearable Patch Detects Skin Cancer: How It WorksMore than 8,500 people are expected to die from melanoma in the U.S. in 2026. Early detection dramatically improves survival, yet the tools for identifying suspicious lesions remain, well, cumbersome.EYECAREFeb 04 2026
PECAA Expands Business Advisory Services to Meet Demand for Customized Private Practice GuidanceBOCA RATON, Fla.—Professional Eye Care Associates of America (PECAA) announced that it is expanding its Business Advisory services due to higher member demand for customized private practice guidance and operational efficiency.EYECAREFeb 04 2026
Foundation Fighting Blindness Names Two Blind Brothers as Presenting Sponsor, Reveals Its Visionary Award Honorees for Night for Sight GalaCOLUMBIA, Md.—The Foundation Fighting Blindness, a private funding source for research on retinal degenerative diseases, announced that it will host its annual Night for Sight gala on May 14, 2026, at Guastavino's in New York City.EYECAREFeb 04 2026
Orbis International Appoints Ann Wang as Chief of StaffNEW YORK—Orbis International announced that it has appointed Ann Wang as its new chief of staff, a newly created position in the organization. As a key member of the executive leadership team, Wang will serve as the principal advisor to the president and CEO.EYECAREFeb 04 2026
Some Blind Fans to Experience Super Bowl With Tactile Device That Tracks BallSome blind and low-vision fans will have unprecedented access to the Super Bowl thanks to a tactile device that tracks the ball, vibrates on key plays and provides real-time audio.EYECAREFeb 03 2026
How to Maximize Movement’s Benefits Against DepressionDepression is like a playground bully. Only instead of your lunch money, it demands your motivation and self-esteem and won’t stop hounding you until you surrender both.EYECAREFeb 03 2026
Inflammation 'Off-Switch' Allows Healing, Prevents Harmful Immune ResponseInflammation can feel like a localized fever, with redness, pain, heat and swelling. It’s how the body works to protect you after an injury, removing damaged tissue or invading bacteria and beginning the healing process.EYECAREFeb 03 2026
Prevent Blindness Marks Age-Related Macular Degeneration and Low Vision Month With New Resources and ProgramsCHICAGO—Prevent Blindness, a nonprofit eye health organization, has declared February as Age-Related Macular Degeneration (AMD) and Low Vision Month in an effort to provide education and various expert-approved resources to the public and eyecare professionals. According to Johns Hopkins Medicine, AMD is the most common cause of severe loss of eyesight among people 50 and…EYECAREFeb 03 2026
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOsLAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, has announced that its board of directors has appointed Warren Foust, president and chief operating officer, and Deborah Andrews, chief financial officer, as interim co-chief executive officers, effective February…EYECAREFeb 03 2026
Vision Innovation Partners Acquires Ophthalmic Associates of AlexandriaANNAPOLIS, Md.—Vision Innovation Partners (VIP), a leading Mid-Atlantic eyecare platform with nearly 70 locations, announced that it has acquired Ophthalmic Associates of Alexandria, a comprehensive ophthalmology practice located in downtown Alexandria, Va.EYECAREFeb 03 2026
Harrow Reaffirms Its 2025 Full-Year Revenue Guidance, Launches OneHarrow InitiativeLAKE FOREST, Calif.—Harrow (Nasdaq: HROW), a North American provider of ophthalmic disease management solutions, has reaffirmed its full-year 2025 revenue guidance, projecting revenue between $270 million and $280 million.EYECAREFeb 03 2026
Unvaccinated Kids Hit Hard With Flu as Pediatric Deaths Rise to 52Fifty-two children have died of the flu so far this season, the Centers for Disease Control and Prevention reported Friday, seemingly putting pediatric deaths on track to outpace last season's record-breaking high.EYECAREFeb 02 2026
Study Finds Surprising Link Between Aspirin in Seniors and Cancer MortalityLow-dose aspirin was not associated with a reduced incidence of cancer in older adults, but was associated with an increased risk of dying of cancer, according to a cohort study of participants from the randomized ASPREE trial.EYECAREFeb 02 2026
Dr. Jason Lake to Moderate VM Summit Panel as ECPs Delve Into ‘What’s in Your Resiliency Toolbox?’NEWARK, N.J.—Jobson Optical Group is pleased to announce its third session at the 2026 Vision Monday Leadership Summit, which will focus on how eyecare professionals are running successful practices and retail businesses that can thrive during these uncertain economic times. In this session titled “What’s in Your Resiliency Toolbox?,” Jason Lake, OD, general manager, PERC…EYECAREFeb 02 2026
Hoya Reports Q3 Revenue Growth, Lifts Full-Year OutlookTOKYO—Hoya Corporation (7741:Tokyo) has announced consolidated revenue of 244.7 billion yen for the third quarter ending December 31, 2025, up 11 percent from the year-ago period, and up 8 percent on a constant currency basis. Pretax profit rose to 110.8 billion yen, a 70 percent increase compared with the year-ago period, up 68 percent with…EYECAREFeb 02 2026
Global Myopia Awareness Coalition Welcomes the New Zealand Association of Optometrists as a New MemberST. LOUIS—The Global Myopia Awareness Coalition (GMAC) has announced that the New Zealand Association of Optometrists (NZAO) has become the newest professional association member of its growing organization.EYECAREFeb 02 2026
The Accessories Council Celebrates Fifth Anniversary of Ac Magazine With Release of Its Winter 2026 IssueNEW YORK—The Accessories Council (Ac), an international, not-for-profit trade association dedicated to boosting global consumer awareness and demand for fashion accessories, has released the Winter 2026 issue of Ac Magazine, celebrating the digital publication's fifth anniversary.EYECAREFeb 02 2026
Sleeping Without Pillows May Help Protect Vision in Glaucoma PatientsSleeping without pillows may actually help people with glaucoma protect their vision. A new, preliminary study suggests stacking pillows under the head at night may raise eye pressure to potentially harmful levels.EYECAREJan 30 2026
Doctors Increasingly See AI Scribes in a Positive Light. But Hiccups Persist.When Jeannine Urban went in for a checkup in November, she had her doctor’s full attention. Instead of typing on her computer keyboard during the exam, Urban’s primary care physician at the Penn Internal Medicine practice in Media, Penn., had an ambient artificial intelligence scribe take notes.EYECAREJan 30 2026
Safilo Group Announces Preliminary 2025 Full-Year Financial ResultsPADUA, Italy—Safilo Group has announced preliminary results for the financial year ended December 31, 2025. The company reported preliminary sales of €983.4 million for full-year 2025, up 1.8 percent at constant exchange rates, following a fourth quarter that saw an increase of 0.4 percent compared with the same period in 2024. At current exchange rates,…EYECAREJan 30 2026
Tenpoint Therapeutics Gains FDA Approval for Yuvezzi, a Combination Eye Drop to Treat PresbyopiaLONDON and SEATTLE—Tenpoint Therapeutics, Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as Brimochol PF.EYECAREJan 30 2026
At The Vision Council’s 2026 Executive Summit, Top Optical Executives Charted the Industry’s Path ForwardALEXANDRIA, Va.—This week, The Vision Council announced it convened over 250 optical industry executives in Amelia Island, Fla., for its 2026 Executive Summit, taking place over the course of three days.EYECAREJan 30 2026
Contact Lens Institute Names 2026 VisionariesWASHINGTON, D.C.—Contact Lens Institute (CLI) has named 17 established and emerging eyecare community leaders as 2026 Visionaries, recognizing a diverse group of professionals from the United States and Canada, according to an announcement.EYECAREJan 30 2026
U.S. Life Expectancy RisesU.S. life expectancy reached 79 in 2024, according to the CDC, which is an all-time high. Head over to ABC News for more.EYECAREJan 29 2026
Mykita Switches Entire Demo Lens Line to Recycled Eastman Tritan RenewBERLIN—Mykita has announced that it will be the first eyewear brand to equip all optical demo lenses with Eastman Tritan Renew, reinforcing its commitment to certified material sourcing. Starting in April 2026, all new Mykita product deliveries will be fitted with demo lenses linked to this recycled material, repurposing waste otherwise destined for landfill, while…EYECAREJan 29 2026
People Who Naturally Stay Up Late May Have Worse Heart Health Than Early RisersThe early bird may not only catch the proverbial worm but also have a healthier heart, new research suggests. People who naturally stay up late, self-described night owls, are likelier to have poor heart health than people with more traditional sleep-wake schedules, according to a study published Wednesday in the Journal of the American Heart…EYECAREJan 29 2026
Eat More, Gain Less Weight on an Unprocessed Food DietPeople who followed a completely unprocessed food diet ate more than 50 percent greater amounts of food than those eating only ultraprocessed foods (UPFs) but still consumed about 330 fewer calories per day on average, a new analysis showed.EYECAREJan 29 2026
Zeiss, 20/20 Magazine Unveil 12 Free CE Course Descriptions Ahead of Eyewear Design Week EventNEW YORK—As part of the Eyewear Design Week 2026 collaboration between The Accessories Council (Ac) and Jobson Publishing, as reported in VMAIL in October 2025, Zeiss will exclusively present a free three-day continuing education event, featuring 12 NYSSO and ABO-approved courses. The event, which will take place March 5 through 7 at 208 W 30th Street,…EYECAREJan 29 2026
Glaukos Receives FDA Approval of NDA Supplement for Re-Administration of iDose TRALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced that the U.S. Food and Drug Administration (FDA) has approved an NDA (new drug application) labeling supplement allowing for re-administration of iDose TR using a repeat treatment protocol.…EYECAREJan 29 2026
Qlaris Bio Adds Robert Warner to Board of DirectorsDEDHAM, Mass.—Qlaris Bio, Inc., a clinical-stage biotechnology company focused on developing therapies for glaucoma, has announced the appointment of Robert Warner to its board of directors, effective immediately.EYECAREJan 29 2026
Eschenbach Sponsors Two Students With Vision Loss to Attend Space Camp for Interested Visually Impaired StudentsDANBURY, Conn.—For the fourth consecutive year, Eschenbach Optik of America, Inc. announced it had sponsored two students with a vision impairment to attend the Space Camp for Interested Visually Impaired Students (SCIVIS). Celebrating its 35th anniversary, the camp was held from September 28 to October 2, 2025, in the U.S. Space and Rocket Center in…EYECAREJan 29 2026
Can Coffee Really Boost Your Mood?When you’re dragging yourself through the day, coffee can offer a reset. It can jolt your brain into action, sharpening your focus and brightening your mood.EYECAREJan 28 2026
Three Ways You’re Misreading the Nutrition Facts LabelIf you’re like most Americans, you probably read the Nutrition Facts label before buying a food product—but are you sure you’re reading it correctly? Estimates suggest one in five people don’t understand it. And even those who think they do may be making common mistakes, experts say.EYECAREJan 28 2026
Vision Monday Announces Its ‘Most Influential Women in Optical’ Honorees for 2026NEWARK, N.J.—Vision Monday has announced its 2026 roster of Most Influential Women in Optical (MIWO). These 35 women of accomplishment were selected by VM’s editors from optical industry nominations, bringing together a class of leaders, collaborators and trailblazers whose stories of success can inspire us all. For this year’s Annual Report, which will be available…EYECAREJan 28 2026
U.S. Optical Industry Value Hits $69.5 Billion in 2025, The Vision Council’s Latest Market inSights Report SaysALEXANDRIA, Va.—The Vision Council has released its latest Market inSights 2025 with 2026 Forecast report that comprehensively analyzes the U.S. optical industry’s performance during 2025. The report shows that the optical industry grew in value to $69.5 billion in 2025, even as Americans purchased fewer optical products and underwent fewer eye exams, the organization noted.…EYECAREJan 28 2026
World Council of Optometry and Alcon Expand Partnership to Promote Dry Eye Disease EducationST. LOUIS—The World Council of Optometry (WCO) and Alcon announced that they have renewed their education initiative to advance dry eye disease professional education on a global basis. Since its launch in 2022, the partnership's wide-ranging initiatives have focused on the mitigation, measurement, and management of dry eye disease. A chronic, painful condition, dry eye…EYECAREJan 28 2026
Registration Now Open for Optometry’s Meeting 2026 and AOA+ in Phoenix, June 17-20ST. LOUIS—The American Optometric Association (AOA) and American Optometric Student Association (AOSA) have announced that registration is now open for Optometry’s Meeting and AOA+, taking place June 17-20 in Phoenix, Ariz.EYECAREJan 28 2026
Johnson & Johnson Marks $100 Million Milestone of MedTech Products Donated Since 2020NEW BRUNSWICK, N.J.—Johnson & Johnson, with support from the Johnson & Johnson (J&J) Foundation, announced that it has donated $100 million of MedTech products since 2020 to help more people around the world gain access to specialized care. The company has also said it planned to contribute an additional $20 million toward programs and impact…EYECAREJan 28 2026
European Countries Including UK Lose Measles Elimination StatusBritain and several other European countries have lost their measles elimination status, the World Health Organization said on Monday, after a jump in infections across the continent.EYECAREJan 27 2026
Tailored Support Strategy May Increase Screening for Unhealthy Alcohol UseA tailored practice facilitation strategy was linked to increased adoption of evidence-based screening and counseling for unhealthy alcohol use among adults at small and medium-sized primary care practices, a quality improvement study suggested.EYECAREJan 27 2026
Review of Optometry: How to Get the Most Out of Expert Guidance Documents in EyecareClinical guidance documents occupy a complicated space in eyecare. In theory, they offer a roadmap, distilling vast amounts of research and expert opinion into practical recommendations doctors can rely on. In practice, they can feel unwieldy, outdated or challenging to apply at the point of care. Many optometrists have experienced the same scenario: searching for…EYECAREJan 27 2026
Congress Trims Funding for CDC Vision Program, Slicing Vision and Eye Health Budget By Nearly One-ThirdNEWARK, N.J.—Congress has included a $2 million reduction to the Centers for Disease Control and Prevention’s Vision and Eye Health Initiative (VHI) in the fiscal year 2026 appropriations package, reducing the program’s budget from $6.5 million to $4.5 million—a cut that amounts to almost one-third of its current resources. The reduction appears in the final…EYECAREJan 27 2026
The AOA+ Pledge Garnered 63 Signatures From the Industry, Marking a Commitment to Support the Next Generation of ODsST. LOUIS—The American Optometric Association (AOA) announced that the AOA+ Pledge has received 63 signatures from organizations across the eye and vision care industry. These organizations are committed to advancing the profession's next generation of leaders.EYECAREJan 27 2026
Authentic Brands Group Completes Transaction Taking Guess? PrivateNEW YORK and LOS ANGELES—Authentic Brands Group (Authentic), a global brand development and licensing platform, and Guess? Inc., announced they have completed the transaction to take Guess? private, effective January 23, 2026. Under the terms of the agreement, which was originally announced in August of 2025, Authentic now owns 51 percent of substantially all Guess?…EYECAREJan 27 2026
Queensway Optometric Centre Named N.A. Practice Fundraising Winner for 2025 World Sight Day ChallengeGOLDEN, Colo.—Optometry Giving Sight (OGS) has announced that Queensway Optometric Centre, located in Mississauga, Ontario, was the top fundraising optometry practice in North America for the 2025 World Sight Day Challenge, raising a total of $10,900. Queensway’s support began in 2009 and since then the practice has collectively contributed more than $145,000 to the Challenge,…EYECAREJan 27 2026
Major Winter Storm Brings Warnings About Heart Attack Risk of Shoveling SnowAs large parts of the U.S. dig out from a major winter storm, health officials are renewing warnings about the serious and potentially deadly risks of shoveling snow, which has been linked to heart attacks.EYECAREJan 26 2026
Melanoma Cases Projected to Increase in 2026Newly diagnosed melanoma cases are projected to rise by 10.6 percent in 2026, according to the updated Skin Cancer Facts & Statistics report from the Skin Cancer Foundation.EYECAREJan 26 2026
FDA Approves Single-Patient Compassionate Use of Urcosimod for the Treatment of Neuropathic Corneal PainLONDON and NEW YORK—OKYO Pharma Limited (Nasdaq: OKYO) announced that the U.S. Food and Drug Administration (FDA) has authorized a single-patient expanded access (compassionate use) investigational new drug (IND) for the use of urcosimod (0.05%) in a patient with neuropathic corneal pain.EYECAREJan 26 2026
Dr. Alicia Feis to Moderate VM Summit Panel as Academic Leaders Explore ‘Incorporating Resilience Into the Next Generation of ODs’NEWARK, N.J.—Jobson Optical Group is pleased to announce that its second session at the 2026 Vision Monday Leadership Summit, titled “Incorporating Resilience Into the Next Generation of ODs,” will be moderated by Alicia Feis, OD, FAAO, dean of Midwestern University's Arizona College of Optometry and president of the Association of Schools and Colleges of Optometry.…EYECAREJan 26 2026
The Vision Council, Independent Optometric Alliance Groups Advocate on Capitol Hill for Affordable Vision Care PoliciesALEXANDRIA, Va.—Representatives from The Vision Council joined independent optometric alliance groups and eyewear manufacturers to advocate on Capitol Hill for policies that support affordable vision care, according to an announcement from The Vision Council.EYECAREJan 26 2026
FDA Approves Single-Patient Compassionate Use of Urcosimod for the Treatment of Neuropathic Corneal PainLONDON and NEW YORK—OKYO Pharma Limited (Nasdaq: OKYO) announced that the U.S. Food and Drug Administration (FDA) has authorized a single-patient expanded access (compassionate use) investigational new drug (IND) for the use of urcosimod (0.05%) in a patient with neuropathic corneal pain.EYECAREJan 26 2026
A 'Holy Grail' Sleep Apnea Pill Could Be on the Market Next YearIn November 2016, Harvard researcher Dr. Luigi Taranto Montemurro was in a lab at Brigham and Women’s Hospital observing the sleep of a middle-aged man with obstructive sleep apnea, who lay in a bed attached to wires to track whether he stopped breathing overnight. Dr. Taranto Montemurro was testing a potential medication, but he didn’t…EYECAREJan 23 2026
Childhood ADHD Linked to Health Problems in Middle AgeChildhood ADHD can set a person up to have poor health in middle age, a new study says. People with ADHD traits at age 10 are likely to have chronic illness and disability at age 46, researchers reported on Jan. 21 in JAMA Network Open.EYECAREJan 23 2026
EssilorLuxottica’s Nuance Audio Glasses Provide Significant Improvements in Hearing Performance, Clinical Findings ShowPARIS—EssilorLuxottica has announced new clinical findings from two studies, conducted in Canada and Australia, evaluating the performance of Nuance Audio Glasses, the group’s open-ear hearing solution built into smart eyewear and intended for adults who have mild to moderate hearing loss. The results of these studies were presented for the first time in Europe during…EYECAREJan 23 2026
Ocular Therapeutix Names David W. Robinson as Global Chief Commercial OfficerBEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ: OCUL), an integrated biopharmaceutical company, announced that David W. Robinson has been appointed as global chief commercial officer, effective immediately. The appointment of Robinson in this new position strategically positions it for success in its global launch of Axpaxli (also known as OTX-TKI), in development for wet age-related macular degeneration…EYECAREJan 23 2026
EssilorLuxottica’s Dr. Carl Spear and Dr. Monica Jong Talk Stellest Lenses in Exclusive VM InterviewNEWARK, N.J.—When EssilorLuxottica’s Stellest lenses received U.S. Food & Drug Administration’s (FDA) market authorization in September 2025, it marked a watershed moment in the global fight against childhood myopia. In a late November video interview with Anne Cooper, editorial director of Vision Monday and 20/20, EssilorLuxottica North America’s chief medical officer Carl Spear, OD, BA,…EYECAREJan 23 2026
Carl Zeiss Meditec Reports Preliminary Revenue for Q1 of Fiscal Year 2025/26JENA, Germany—Carl Zeiss Meditec AG (ISIN: DE0005313704) has reported preliminary revenue of €467 million for the first quarter of its fiscal year 2025/26 ending December 31, 2025, down from €490 million in the prior-year period.EYECAREJan 23 2026
SUNY College of Optometry Appoints Marina Su, OD, VP for Clinical Affairs and Executive Director of University Eye CenterNEW YORK—SUNY College of Optometry has announced the appointment of Marina Su, OD, FAAO, as vice president for clinical affairs and executive director of the University Eye Center, effective immediately. Dr. Su brings more than 17 years of experience in clinical practice, education and health care leadership.EYECAREJan 23 2026
Vision Expo’s NOW Awards 2026 Submissions Are Open to Entire Global Eyewear CommunityNORWALK, Conn.—Vision Expo, organized by The Vision Council and RX, announced that submissions for the NOW Awards are open to the entire global eyewear community this year, extending beyond the Vision Expo show floor.EYECAREJan 23 2026
Using AI for Advice or Other Personal Reasons Is Linked to Depression and AnxietyPeople who interact with chatbots for emotional support or other personal reasons are likelier to report symptoms of depression or anxiety, a new study finds. The researchers from Mass General Brigham surveyed 20,847 mostly white men and women in the United States about their AI usage and mental health symptoms.EYECAREJan 22 2026
Johnson & Johnson Reports Q4 and Full-Year 2025 Sales Growth, Issues 2026 GuidanceNEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) yesterday announced fourth-quarter and full-year 2025 financial results, reporting year-over-year fourth quarter sales growth of 9.1 percent to $24.6 billion and full-year reported sales growth of 6.0 percent to $94.2 billion. For the fourth quarter, operational growth was reported at 7.1 percent and adjusted operational growth was 6.1…EYECAREJan 22 2026
PECAA and VSP Vision Extend Enhanced Vision Exam Rebate Through 2026BOCA RATON, Fla. and RANCHO CORDOVA, Calif—The Professional Eye Care Associates of America (PECAA) and VSP Vision today announced that the limited-time enhancement of the VSP Vision Exam Rebate has been extended through 2026.EYECAREJan 22 2026
Tickets and Sponsorships Available for the Prevent Blindness Person of Vision Award Gala Honoring Advancing Eyecare’s Jim McGrannCHICAGO—Tickets and sponsorships are still available for the 2026 Prevent Blindness Person of Vision Award gala honoring Jim McGrann, CEO of Advancing Eyecare, according to an announcement from the nonprofit eye health organization.EYECAREJan 22 2026
Art Optical Awards Specialty Contact Lens Travel GrantsGRAND RAPIDS, Mich.—Art Optical Contact Lens, Inc., a provider of custom contact lenses, in partnership with Contamac, a manufacturer of contact and intraocular lens materials, recently named the winners of their Specialty Contact Lens Travel Grants.EYECAREJan 22 2026
AI Is Poised to Drive Smarter Business Growth Through 2030, Study SaysARMONK, N.Y.—New research from the IBM Institute for Business Value has revealed that nearly eight in 10 (79 percent) surveyed executives expect AI will significantly contribute to their revenue by 2030—up from 40 percent today—but few senior managers (24 percent) have a clear view of where that revenue will come from. Despite this uncertainty, investment…EYECAREJan 21 2026
Pediatric Flu Deaths Double Amid Decline in Cases. See Latest Numbers.Flu pediatric deaths have doubled week-over-week, according to new Centers for Disease Control and Prevention data, despite influenza numbers continuing on a downward trend overall. Fifteen new influenza-associated pediatric deaths were reported to the CDC the week ending on Saturday, Jan. 10, bringing the season total to 32.EYECAREJan 21 2026
Rochester Optical Manufacturing Company Appoints Stuart Jolly as VP of Business Strategy and SalesROCHESTER, N.Y.—Rochester Optical Manufacturing Company, a provider of precision ophthalmic lenses and optical solutions, has announced the appointment of Stuart Jolly as vice president of business strategy and sales, effective immediately. In this new strategic role, Jolly will report directly to Patrick Ho, Rochester Optical’s CEO, and will lead its global commercial growth initiatives, customer…EYECAREJan 21 2026
Expo Attendees Will Receive Free Admission to Rock4Sight Fundraiser Concert on March 13 During Vision Expo 2026ORLANDO, Fla.—The collective of musicians and singers who perform under the Rock4Sight banner will perform at Blake Shelton’s Bar, Ole Red, on Friday, March 13, according to an announcement from organizers of the annual charity concert.EYECAREJan 21 2026
Jobson Optical Research Shares Updated Report on Use of Digital Solutions by ECPsNEWARK, N.J.—In December 2025, Jobson Optical Research surveyed 458 eyecare professionals (ECPs) regarding their use of digital solutions in their practices. The 44-page report, titled 2025 Digital Solutions for ECPs, offers insights on how eyecare practitioners utilize social media, online reviews, as well as their own websites or apps to run their practices. ECPs responded…EYECAREJan 21 2026
Europa Eyewear Announces Retirement of Longtime President Jerry Wolowicz, Names Andy Skitmore as SuccessorVERNON HILLS, Ill.—Europa Eyewear, a leading independent eyewear company, today announced the retirement of longtime president Jerry Wolowicz after more than four decades of service. It also announced the appointment of eyewear industry executive Andy Skitmore as his successor. Following a 43-year tenure with the company, Wolowicz will retire at the end of February this…EYECAREJan 20 2026
Has Private Equity Taken the ‘Beauty’ Out of Practicing Ophthalmology? Will Publicly Held Companies Do Any Better?As chief of ophthalmology at a Veterans Affairs (VA) medical center, Ankit Shah, MD, mentors trainees who might be thinking about going into private practice. But he has seen those opportunities dry up—first as private equity (PE) firms began buying ophthalmology practices, and, in the past year, publicly traded corporations have begun buying out the…EYECAREJan 20 2026
The Vision Council’s inSights Report Highlights Consumer Vision Care Priorities for Q4 2025ALEXANDRIA, Va.—The Vision Council released new research last week highlighting consumer habits about optical products and services for the last quarter of 2025. The report, titled Consumer inSights Q4 2025, reveals the behaviors and attitudes of U.S. adults related to vision correction, managed vision care, eye exams, prescription eyewear, reading glasses, and plano sunglasses, The…EYECAREJan 20 2026
BVI Appoints Jim Hollingshead as President and Chief Executive OfficerWALTHAM, Mass.—BVI, a global ophthalmic device company, has announced the appointment of Jim Hollingshead as president and chief executive officer (CEO). Hollingshead succeeds Shervin Korangy, who the company said will continue to serve as an advisor to BVI and begin a new role as senior advisor to TPG Capital. Hollingshead has over 20 years of…EYECAREJan 20 2026
World Council of Optometry Sets Theme for 2026 World Optometry WeekST. LOUIS—The World Council of Optometry (WCO) has announced that "A Shared Vision: Collaboration in Global Eye Care" will be the theme for World Optometry Week 2026, which will run from March 22–28. This annual event, which includes World Optometry Day on March 23, is a celebration of optometry's essential contribution to global health and…EYECAREJan 20 2026
Early Registration Pricing for United Opticians Association Leadership Conference Closes on January 31, 2026LEXINGTON, Ky.—The United Opticians Association (UOA) is reminding members that early registration pricing for the organization's One Vision | One Voice | One UOA Leadership Conference is available through January 31, 2026.EYECAREJan 20 2026
Menicon Ends Rose K Manufacturing Partnership With Blanchard Contact LensesNAKA-KU, NAGOYA, Japan—Menicon Co., Ltd, a global contact lens manufacturer, announced that it has concluded its Rose K manufacturing partnership with Blanchard Contact Lenses, a division of CooperVision, effective December 31, 2025.EYECAREJan 20 2026
Vision Monday's 2026 Industry Calendar Is Now AvailableNEWARK, N.J.—Vision Monday has released its 2026 Industry Calendar of optical events. From opti in Munich, to Mido in Milan as well as Vision Expo, SECO and many more, the calendar takes a look at both domestic and international events.EYECAREJan 20 2026
Does Too Much Screen Time Before Bed Affect Sleep, Eye Health?NEWARK, N.J.—The average American adult spends more than 10 hours a day online, according to a recent Optimum (Altice) survey. This significant screen time—from devices like laptops, televisions, tablets, and virtual reality headsets—can harm eye health and sleep quality, experts suggest, with the use of smartphones right before or shortly after getting into bed being…EYECAREJan 16 2026
Financial Stress May Be as Bad for the Heart as Traditional Risk Factors for Cardiovascular DiseaseWorrying about money and food may age the heart even faster than traditional risk factors of cardiovascular disease, according to a new study published in the journal Mayo Clinic Proceedings.EYECAREJan 16 2026
The Vision Council Releases Revision of ANSI Z80.1–2025, Prescription Ophthalmic Lenses RecommendationsALEXANDRIA, Va.—The Vision Council, as the secretariat administrator for Accredited Standards Committee Z80, has announced the revision of technical standard titled, “ANSI ASC Z80.1-2025, Prescription Ophthalmic Lenses - Recommendations.” This revision supersedes the 2020 Standard and represents five years of work by a team of industry experts, led by chair Dick Whitney, vice chair Rick…EYECAREJan 16 2026
STAAR Surgical and Broadwood Partners Announce Changes to Leadership, Board of DirectorsLAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a leading developer of phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, and Broadwood Partners, L.P. and its affiliates have announced that Neal C. Bradsher and Richard T. LeBuhn of Broadwood and Christopher Wang of Yunqi Capital have joined STAAR’s board…EYECAREJan 16 2026
The Vision Council Releases Revision of ANSI Z80.1–2025, Prescription Ophthalmic Lenses RecommendationsALEXANDRIA, Va.—The Vision Council, as the secretariat administrator for Accredited Standards Committee Z80, has announced the revision of technical standard titled, “ANSI ASC Z80.1-2025, Prescription Ophthalmic Lenses - Recommendations.” This revision supersedes the 2020 Standard and represents five years of work by a team of industry experts, led by chair Dick Whitney, vice chair Rick…EYECAREJan 16 2026
Mondottica Group Secures B Corp Status, Advancing Its Commitment to SustainabilityNEW YORK—Mondottica Group has advanced its commitment to sustainability by securing its B Corporation status. This certification, granted by B Lab, signifies that the for-profit organization has met rigorous standards for high levels of social and environmental performance, accountability and transparency.EYECAREJan 16 2026
EssilorLuxottica’s Nuance Audio Glasses Provide Significant Improvements in Hearing Performance, Clinical Findings ShowPARIS—EssilorLuxottica has announced new clinical findings from two studies evaluating the performance of Nuance Audio Glasses, the group’s open-ear hearing solution built into smart eyewear and intended for adults who have mild to moderate hearing loss.EYECAREJan 16 2026
Student Struggle With Mental Health Continues, eLuma FindsAmerican students continue to struggle with mental health challenges, according to the “State of Student Mental Health Report 2025” from eLuma, a provider of behavioral health and special education services for K-12 schools. Despite growing student need, the report reveals that 52 percent of public schools report they are not able to effectively provide mental…EYECAREJan 15 2026
Global Share of Companies Facing Biodiversity and Greenwashing Risks Doubles, Study FindsRecent research from RepRisk, a global leader in environmental, social, and governance (ESG) data technology, revealed that the global share of companies linked to both greenwashing and biodiversity risks has doubled over the past five years—increasing from 3 percent in 2021 to 6 percent in 2025, according to RepRisk's fourth annual report on greenwashing. The…EYECAREJan 15 2026
Patients’ Cardiovascular Risk Score May Predict Development of Multiple Eye Diseases, New Study ShowsLOS ANGELES—A cardiovascular risk score, already routinely used in primary care, may predict who will develop serious eye diseases, according to a UCLA Health study published earlier this month. UCLA Health said researchers involved in the study found that people with higher cardiovascular risk scores were “significantly more likely to develop conditions including age-related macular…EYECAREJan 15 2026
The Key to Living Longer Is Small Changes in Sleep, Diet and Exercise, New Research FindsIf your goal is to be healthier in 2026, you don’t have to overhaul your habits, follow a strict diet or spend hours at the gym. Taking baby steps to collectively improve three of the most important behaviors—sleep, exercise and nutrition—may not only boost health but also lengthen your life, new research shows.EYECAREJan 15 2026
Prevent Blindness to Roll Out the ‘It Started With an Eye Exam’ Campaign on January 19CHICAGO—Prevent Blindness, a nonprofit eye health organization, has announced it is launching its second iteration of the “It Started With an Eye Exam” campaign beginning on January 19. The goal of the campaign is to spread eye health awareness by using patient testimonials that encourage the public to share their own stories about the positive…EYECAREJan 15 2026
Eyebot and The Framery at 1-800 Contacts Partner to Create End-to-End Retail Optical ExperienceLAS VEGAS—Eyebot, a developer of automated vision testing technology, and The Framery, an online platform for prescription glasses at 1-800 Contacts, have announced a new partnership to offer a joint, end-to-end optical retail experience, which is expected to launch later this year.EYECAREJan 15 2026
Glaukos Reports Preliminary Q4 and 2025 Results, Reaffirms 2026 Revenue GuidanceALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company, has announced its preliminary, unaudited net sales for the fourth quarter and full year ended December 31, 2025, and reaffirmed its full year 2026 revenue guidance.EYECAREJan 15 2026
Sight Sciences Releases Preliminary Q4 and 2025 Financial ResultsMENLO PARK, Calif.—Sight Sciences, Inc., (Nasdaq: SGHT), an eyecare technology company, has reported select preliminary, unaudited financial highlights for the fourth quarter and full year ended December 31, 2025.EYECAREJan 15 2026
Patients’ Cardiovascular Risk Score May Predict Development of Multiple Eye Diseases, New Study ShowsLOS ANGELES—A cardiovascular risk score, already routinely used in primary care, may predict who will develop serious eye diseases, according to a UCLA Health study published earlier this month. The study is published in the American Academy of Ophthalmology’s journal Ophthalmology.EYECAREJan 15 2026
Pseudopodia lentis and preretinal deposit in systemic amyloidosis Eye, Published online: 13 February 2026; doi:10.1038/s41433-026-04259-wPseudopodia lentis and preretinal deposit in systemic amyloidosisEyeFeb 13 2026
Type 1 macular neovascularisation associated with choroidal artery compression Eye, Published online: 13 February 2026; doi:10.1038/s41433-026-04291-wType 1 macular neovascularisation associated with choroidal artery compressionEyeFeb 13 2026
Ultra–high-resolution visualisation of the human ciliary body using Hierarchical Phase-Contrast Tomography (HiP-CT) Eye, Published online: 13 February 2026; doi:10.1038/s41433-026-04300-yUltra–high-resolution visualisation of the human ciliary body using Hierarchical Phase-Contrast Tomography (HiP-CT)EyeFeb 13 2026
Comment on: “Ophthalmic complications associated with COVID-19: a large US national database analysis” Eye, Published online: 13 February 2026; doi:10.1038/s41433-026-04290-xComment on: “Ophthalmic complications associated with COVID-19: a large US national database analysis”EyeFeb 13 2026
An educational figure of nystagmus Eye, Published online: 13 February 2026; doi:10.1038/s41433-026-04294-7An educational figure of nystagmusEyeFeb 13 2026
Tubercular serpiginous-like choroiditisEye, Published online: 11 February 2026; doi:10.1038/s41433-026-04293-8Tubercular serpiginous-like choroiditisEyeFeb 11 2026
Comment on: ‘Management of uveitic and chorioretinal conditions in pregnancy’Eye, Published online: 11 February 2026; doi:10.1038/s41433-026-04301-xComment on: ‘Management of uveitic and chorioretinal conditions in pregnancy’EyeFeb 11 2026
Three-dimensional choroidal vessels assessment in age-related macular degeneration: a follow-up studyEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04296-5Three-dimensional choroidal vessels assessment in age-related macular degeneration: a follow-up studyEyeFeb 10 2026
OphthoEvidence report: Protocol for quality appraisal of clinical practice guidelines in ophthalmologyEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04283-wOphthoEvidence report: Protocol for quality appraisal of clinical practice guidelines in ophthalmologyEyeFeb 10 2026
Association between PCSK9 inhibitor use and risk of age-related macular degenerationEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04287-6Association between PCSK9 inhibitor use and risk of age-related macular degenerationEyeFeb 10 2026
Comparative effectiveness of varying hyperbaric oxygen protocols in the treatment of acute central retinal artery occlusionEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04298-3Comparative effectiveness of varying hyperbaric oxygen protocols in the treatment of acute central retinal artery occlusionEyeFeb 10 2026
Selective laser trabeculoplasty: adverse effects of prior topical anti-glaucoma medicationEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04273-ySelective laser trabeculoplasty: adverse effects of prior topical anti-glaucoma medicationEyeFeb 10 2026
Diabetic macular atrophy, a pilot exploration of its characteristics, progression, and visual implicationsEye, Published online: 09 February 2026; doi:10.1038/s41433-026-04288-5Diabetic macular atrophy, a pilot exploration of its characteristics, progression, and visual implicationsEyeFeb 09 2026
Prevalence and associations of central serous chorioretinopathy in a population aged 50+ years. The Beijing Eye StudyEye, Published online: 09 February 2026; doi:10.1038/s41433-026-04269-8Prevalence and associations of central serous chorioretinopathy in a population aged 50+ years. The Beijing Eye StudyEyeFeb 09 2026
Beyond placoid: diverse clinical presentations and functional outcomes of acute syphilitic posterior placoid chorioretinopathyEye, Published online: 09 February 2026; doi:10.1038/s41433-026-04272-zBeyond placoid: diverse clinical presentations and functional outcomes of acute syphilitic posterior placoid chorioretinopathyEyeFeb 09 2026
Impact of multiple births on retinopathy of prematurity in preterm infantsEye, Published online: 06 February 2026; doi:10.1038/s41433-026-04247-0Impact of multiple births on retinopathy of prematurity in preterm infantsEyeFeb 06 2026
Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitorsEye, Published online: 06 February 2026; doi:10.1038/s41433-026-04240-7Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitorsEyeFeb 06 2026
Early vitrectomy for myopic foveoschisis before foveal detachmentEye, Published online: 06 February 2026; doi:10.1038/s41433-026-04261-2Early vitrectomy for myopic foveoschisis before foveal detachmentEyeFeb 06 2026
Trocar sleeve adapter accelerates silicone oil injection in real-world vitreoretinal surgeryEye, Published online: 06 February 2026; doi:10.1038/s41433-026-04279-6Trocar sleeve adapter accelerates silicone oil injection in real-world vitreoretinal surgeryEyeFeb 06 2026
Hyperreflective choroidal foci may predict pachychoroid macular atrophy development in central serous chorioretinopathyEye, Published online: 05 February 2026; doi:10.1038/s41433-026-04277-8Hyperreflective choroidal foci may predict pachychoroid macular atrophy development in central serous chorioretinopathyEyeFeb 05 2026
Neurotrophic keratopathy in childhood: advances in understanding of pathogenesis and managementEye, Published online: 05 February 2026; doi:10.1038/s41433-026-04278-7Neurotrophic keratopathy in childhood: advances in understanding of pathogenesis and managementEyeFeb 05 2026
Biologic therapy is associated with reduced ocular disease in psoriasis: a real-world studyEye, Published online: 05 February 2026; doi:10.1038/s41433-026-04274-xBiologic therapy is associated with reduced ocular disease in psoriasis: a real-world studyEyeFeb 05 2026
Infographic: Randomized trial of bilateral gene therapy injection for m.11778 G &gt; A <i>MT-ND4</i> Leber optic neuropathy (REFLECT Trial)Eye, Published online: 05 February 2026; doi:10.1038/s41433-026-04266-xInfographic: Randomized trial of bilateral gene therapy injection for m.11778 G > A MT-ND4 Leber optic neuropathy (REFLECT Trial)EyeFeb 05 2026
Pigmentary retinopathy, oculomotor apraxia and esotropia: a widespread and intense ocular involvement in congenital glycosylation defectEye, Published online: 05 February 2026; doi:10.1038/s41433-026-04268-9Pigmentary retinopathy, oculomotor apraxia and esotropia: a widespread and intense ocular involvement in congenital glycosylation defectEyeFeb 05 2026
Leveraging structured EMR data for efficient patient prescreening: a practical approach to reducing screen-failure rates in Light Touch TrialEye, Published online: 04 February 2026; doi:10.1038/s41433-026-04267-wLeveraging structured EMR data for efficient patient prescreening: a practical approach to reducing screen-failure rates in Light Touch TrialEyeFeb 04 2026
Infographic: bevacizumab eliminates the angiogenic threat of retinopathy of prematurity (BEAT-ROP study)Eye, Published online: 03 February 2026; doi:10.1038/s41433-026-04285-8Infographic: bevacizumab eliminates the angiogenic threat of retinopathy of prematurity (BEAT-ROP study)EyeFeb 03 2026
Infographic: FAME (fluocinolone acetonide for macular edema) trials of ILUVIEN® vitreous sustained-delivery inserts for diabetic macular oedemaEye, Published online: 03 February 2026; doi:10.1038/s41433-026-04271-0Infographic: FAME (fluocinolone acetonide for macular edema) trials of ILUVIEN® vitreous sustained-delivery inserts for diabetic macular oedemaEyeFeb 03 2026
Surgical management of aqueous misdirection by endoscopic vitrectomy with Hyaloido-Zonulo-IridectomyEye, Published online: 03 February 2026; doi:10.1038/s41433-026-04265-ySurgical management of aqueous misdirection by endoscopic vitrectomy with Hyaloido-Zonulo-IridectomyEyeFeb 03 2026
Exposure of the Supramid suture—an uninvited disasterEye, Published online: 03 February 2026; doi:10.1038/s41433-026-04275-wExposure of the Supramid suture—an uninvited disasterEyeFeb 03 2026
Proposed Idiopathic Multiple Retinal Telangiectasias (IMRT)Eye, Published online: 03 February 2026; doi:10.1038/s41433-026-04276-9Proposed Idiopathic Multiple Retinal Telangiectasias (IMRT)EyeFeb 03 2026
A hypothesis for the characteristic parafoveal toxicity observed in hydroxychloroquine retinopathyEye, Published online: 31 January 2026; doi:10.1038/s41433-026-04270-1A hypothesis for the characteristic parafoveal toxicity observed in hydroxychloroquine retinopathyEyeJan 31 2026
SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degenerationEye, Published online: 30 January 2026; doi:10.1038/s41433-026-04260-3SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degenerationEyeJan 30 2026
An updated analysis of large language model performance on ophthalmology speciality examinationsEye, Published online: 30 January 2026; doi:10.1038/s41433-026-04262-1An updated analysis of large language model performance on ophthalmology speciality examinationsEyeJan 30 2026
Schwartz-Matsuo syndromeEye, Published online: 30 January 2026; doi:10.1038/s41433-026-04258-xSchwartz-Matsuo syndromeEyeJan 30 2026
Circumventing exenteration for giant basal cell carcinoma by neoadjuvant SonidegibEye, Published online: 30 January 2026; doi:10.1038/s41433-026-04253-2Circumventing exenteration for giant basal cell carcinoma by neoadjuvant SonidegibEyeJan 30 2026
Validation of moles score for small choroidal melanomas: impact of assuming enlargement for telemedicine in sizable lesionsEye, Published online: 29 January 2026; doi:10.1038/s41433-026-04264-zValidation of moles score for small choroidal melanomas: impact of assuming enlargement for telemedicine in sizable lesionsEyeJan 29 2026
Distinctive imaging of rare anterior subcapsular lens deposits in Fabry diseaseEye, Published online: 23 January 2026; doi:10.1038/s41433-026-04255-0Distinctive imaging of rare anterior subcapsular lens deposits in Fabry diseaseEyeJan 23 2026
COVID-19 vaccination and retinal vascular occlusion: still open for debate?Eye, Published online: 23 January 2026; doi:10.1038/s41433-026-04256-zCOVID-19 vaccination and retinal vascular occlusion: still open for debate?EyeJan 23 2026
Prevalence of diplopia among giant cell arteritis patients: a systematic review and meta-analysisEye, Published online: 22 January 2026; doi:10.1038/s41433-026-04254-1Prevalence of diplopia among giant cell arteritis patients: a systematic review and meta-analysisEyeJan 22 2026
The prevalence of unsuspected intraocular malignancy following eye removalEye, Published online: 22 January 2026; doi:10.1038/s41433-025-04224-zThe prevalence of unsuspected intraocular malignancy following eye removalEyeJan 22 2026
Grasping the batonEye, Published online: 22 January 2026; doi:10.1038/s41433-026-04251-4Grasping the batonEyeJan 22 2026
Comment on: Significance of serum biomarkers in preterm infants screened for retinopathy of prematurity: a systematic review and meta-analysisEye, Published online: 22 January 2026; doi:10.1038/s41433-026-04244-3Comment on: Significance of serum biomarkers in preterm infants screened for retinopathy of prematurity: a systematic review and meta-analysisEyeJan 22 2026
Allied Ophthalmic Personnel: Backbone of Aravind’s Eye Care and Social MissionEye, Published online: 21 January 2026; doi:10.1038/s41433-026-04249-yAllied Ophthalmic Personnel: Backbone of Aravind’s Eye Care and Social MissionEyeJan 21 2026
Comment on: ‘Timing of posterior capsular rupture’Eye, Published online: 21 January 2026; doi:10.1038/s41433-026-04241-6Comment on: ‘Timing of posterior capsular rupture’EyeJan 21 2026
Correction: Artificial intelligence-based analysis of retinal fluid volume dynamics in neovascular age-related macular degeneration and association with vision and atrophyEye, Published online: 21 January 2026; doi:10.1038/s41433-025-04232-zCorrection: Artificial intelligence-based analysis of retinal fluid volume dynamics in neovascular age-related macular degeneration and association with vision and atrophyEyeJan 21 2026
Inflammatory cytokines are not associated with early age-related macular degeneration: a two-sample Mendelian randomisation studyEye, Published online: 20 January 2026; doi:10.1038/s41433-025-04225-yInflammatory cytokines are not associated with early age-related macular degeneration: a two-sample Mendelian randomisation studyEyeJan 20 2026
Optimised multivariable prediction model to predict treatment requirement in preterm infants with retinopathy of prematurityEye, Published online: 19 January 2026; doi:10.1038/s41433-026-04245-2Optimised multivariable prediction model to predict treatment requirement in preterm infants with retinopathy of prematurityEyeJan 19 2026
Farewell Editorial by Professor Sobha Sivaprasad, Editor-in-Chief from 2018–2025Eye, Published online: 17 January 2026; doi:10.1038/s41433-026-04250-5Farewell Editorial by Professor Sobha Sivaprasad, Editor-in-Chief from 2018–2025EyeJan 17 2026
The effect of selective laser trabeculoplasty on the intraocular pressure of the contralateral eye – a systematic review and meta-analysisEye, Published online: 17 January 2026; doi:10.1038/s41433-025-04222-1The effect of selective laser trabeculoplasty on the intraocular pressure of the contralateral eye – a systematic review and meta-analysisEyeJan 17 2026
Orthoptic stroke services in the UK and Ireland: how have they evolved?Eye, Published online: 17 January 2026; doi:10.1038/s41433-026-04243-4Orthoptic stroke services in the UK and Ireland: how have they evolved?EyeJan 17 2026
Comment on: “Current and emerging strategies for myopia control: a narrative review of optical, pharmacological, behavioural, and adjunctive therapies”Eye, Published online: 17 January 2026; doi:10.1038/s41433-025-04217-yComment on: “Current and emerging strategies for myopia control: a narrative review of optical, pharmacological, behavioural, and adjunctive therapies”EyeJan 17 2026
Pickleball and Ball Sports-Related Ocular Trauma in the United StatesEye, Published online: 16 January 2026; doi:10.1038/s41433-025-04192-4Pickleball and Ball Sports-Related Ocular Trauma in the United StatesEyeJan 16 2026
Infographic: SPECTRUM: study design of the global real-world study of aflibercept 8 mg in the treatment of neovascular age-related macular degeneration and diabetic macular edemaEye, Published online: 16 January 2026; doi:10.1038/s41433-025-04140-2Infographic: SPECTRUM: study design of the global real-world study of aflibercept 8 mg in the treatment of neovascular age-related macular degeneration and diabetic macular edemaEyeJan 16 2026
Predicting progression to proliferative diabetic retinopathy using automated versus manual quantification of retinal haemorrhagesEye, Published online: 16 January 2026; doi:10.1038/s41433-025-04205-2Predicting progression to proliferative diabetic retinopathy using automated versus manual quantification of retinal haemorrhagesEyeJan 16 2026
Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panelEye, Published online: 16 January 2026; doi:10.1038/s41433-025-04180-8Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panelEyeJan 16 2026
Short-pulse multi-spot PRP, burn size and the risk of undertreatmentEye, Published online: 15 January 2026; doi:10.1038/s41433-026-04248-zShort-pulse multi-spot PRP, burn size and the risk of undertreatmentEyeJan 15 2026
Thyroid Eye Disease and the Prevalence of Human Papillomavirus This case-control study examines human papillomavirus and thyroid eye disease data from a large-scale centralized electronic health record database network.JAMA Ophthalmology Online FirstFeb 12 2026
Bisphosphonate-Associated Orbital Inflammation This case report describes a diagnosis of preseptal and orbital inflammation after intravenous infusion of the bisphosphonate zoledronate for osteoporosis in a woman aged 64 years.JAMA Ophthalmology Online FirstFeb 12 2026
New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes This observational study emulates a target trial evaluating the risk of NAION associated with initiation of semaglutide, compared with a sodium-glucose cotransporter-2 inhibitor as second-line therapy for type 2 diabetes in a nationwide cohort of US veterans.JAMA Ophthalmology Online FirstFeb 12 2026
Iris Trabecular Contact on OCT in Angle Closure ProgressionThis cohort study investigates the association between iridotrabecular contact on anterior segment optical coherence tomography images and risk of 72-month progression from primary angle closure suspect to primary angle closure.JAMA Ophthalmology Online FirstFeb 05 2026
Relative Risk of Neovascular Age-Related Macular Degeneration Following Cataract SurgeryThis cohort study examines the association between cataract surgery and progression of age-related macular degeneration in adults 60 years or older.JAMA Ophthalmology Online FirstFeb 05 2026
Corneal Abrasion Leading to Stromal Melt in a Patient With MyopiaThis case report describes an incidence of corneal melt in a patient with a history of corneal insert implantation 26 years prior due to myopia.JAMA Ophthalmology Online FirstFeb 05 2026
Safety Evaluation of 4 Red Light Therapy Devices for MyopiaThis quality improvement study assesses the optical output and safety classification of 4 commercially available red light therapy devices for myopia management using American National Standards Institute guidelines.JAMA Ophthalmology Online FirstFeb 05 2026
Evaluating Language Concordance in Ophthalmic CareThis Viewpoint emphasizes the importance of meeting the needs of patients with limited English proficiency in ophthalmic care.JAMA Ophthalmology Online FirstJan 29 2026
Are We Treating Pressure or Treating Patients?This Viewpoint discusses the potential cognitive bias of what is considered elevated intraocular pressure and consquences of this bias for clinical care.JAMA Ophthalmology Online FirstJan 29 2026
Validation of a Novel Geographic Outcome MeasureThis prognostic study evaluates a novel geographic atrophy outcome measure for tracking geographic atrophy in age-related macular degeneration.JAMA Ophthalmology Online FirstJan 29 2026
Ultra-Widefield Fluorescein Angiographic Quantitative Leakage in Nonproliferative Diabetic RetinopathyThis cohort study is a post hoc analysis of data from a DRCR Retina Network study that examines the association of retinal leakage on ultra-widefield fluorescein angiography with diabetic retinopathy progression and complications.JAMA Ophthalmology Online FirstJan 29 2026
Fatty Acid Supplementation and Retinopathy of PrematurityThis secondary analysis of a randomized clinical trial examines what risk factors for retinopathy of prematurity are influenced by supplementation with arachidonic acid and docosahexaenoic acid and their interactions with severe retinopathy of prematurity.JAMA Ophthalmology Online FirstJan 29 2026
Automated FA Leakage Measurement to Predict NPDR ProgressionIn this issue of JAMA Ophthalmology, Ehlers et al used data from the DRCR Retina Network Protocol AA clinical trial to generate new evidence on the potential predictive role of the panretinal leakage index (LI) for nonproliferative diabetic retinopathy (NPDR) progression.JAMA Ophthalmology Online FirstJan 29 2026
Traumatic Unilateral Peripheral Arteriolar OcclusionsThis case report discusses a diagnosis of peripheral arteriolar sclerosis and nonperfusion in the left eye of a male patient in his 20s after a contusion injury and subsequent treatment for traumatic iritis and ocular hypertension.JAMA Ophthalmology Online FirstJan 29 2026
Cardiopulmonary Disease in Retinal Images of Premature InfantsThis diagnostic study investigates if an artificial intelligence algorithm can diagnose bronchopulmonary dysplasia or pulmonary hypertension in the retinal images of preterm infants obtained during retinopathy of prematurity screening examinations.JAMA Ophthalmology Online FirstJan 22 2026
Context for Large Language Model Evaluation in Ophthalmology—ReplyIn Reply We thank Kameda and Kaneko for their thoughtful comments on our recent article benchmarking OpenAI’s o1 large language model (LLM) performance on ophthalmological knowledge and reasoning tasks against that of previous general LLMs. Pertaining to the query on the LLM’s temperature setting, we would like to clarify that we evaluated the LLM at…JAMA Ophthalmology Online FirstJan 22 2026
Context for Large Language Model Evaluation in OphthalmologyTo the Editor Srinivasan et al reported relatively impressive performance of OpenAI o1 on an ophthalmology subset of questions from the Medical Multiple-Choice Question Answering (MedMCQA) dataset (6990 multiple-choice questions) and compared it with other contemporary large language models (LLMs). Their report advances the conversation on model accuracy and usefulness in eye care.JAMA Ophthalmology Online FirstJan 22 2026
Context for Large Language Model Evaluation in OphthalmologyTo the Editor We read with interest the recent article by Srinivasan et al, which provides insights into the performance of large language models in ophthalmology, particularly the OpenAI o1 model. We wish to raise a minor point regarding the temperature parameter settings. The study notes that the o1 model was evaluated using its default…JAMA Ophthalmology Online FirstJan 22 2026
Language Accessibility at Select Academic Ophthalmology CentersThis cross-sectional study examines whether ophthalmologist language skills at US ophthalmology centers aligns with the linguistic needs of surrounding limited English proficiency populations.JAMA Ophthalmology Online FirstJan 15 2026
Outcome Metrics in Myopia Control Trials—ReplyIn Reply We agree that the choroidal thickening caused by 0.04% atropine or orthokeratology may lead to an underestimation of axial elongation when based on the surface of the cornea to the surface of the retina rather than elongation of the globe from the surface of the cornea to the posterior surface of the sclera.…JAMA Ophthalmology Online FirstJan 15 2026
Outcome Metrics in Myopia Control TrialsTo the Editor A recent contribution to our understanding of pediatric myopia control is the randomized clinical trial by Xu and colleagues comparing 0.04% atropine, 0.01% atropine, and orthokeratology over a 2-year period in Chinese children aged 8 to 15 years with moderate myopia. The trial found that children receiving 0.04% atropine had a significantly…JAMA Ophthalmology Online FirstJan 15 2026
Pedunculated Palpebral Conjunctival PapillomaThis case report describes the diagnosis and treatment of conjunctival papilloma in a patient aged 54 years who presented with a 3-month history of a painless lower left eyelid lesion.JAMA Ophthalmology Online FirstJan 15 2026

© ECM All rights reserved 2026.